Anesthetic management in corticobasal degeneration with central sleep apnea: A case report

• Published in: Journal of dental anesthesia and pain medicine: JDAPM Vol. 19; no. 4; pp. 235 - 238
• Main Authors: Shionoya, Yoshiki, Nakamura, Kiminari, Sunada, Katsuhisa
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Dental Society of Anesthsiology 01-08-2019; 대한치과마취과학회
• Subjects: Case Report; 치의학; Propofol; Corticobasal Degeneration; Laryngeal Mask Airway; Sleep Apnea
• ISSN: 2383-9309; 2383-9317
• DOI: 10.17245/jdapm.2019.19.4.235

Corticobasal degeneration (CBD) is a rare neurodegenerative disease characterized by dystonia, cognitive deficits, and an asymmetric akinetic-rigid syndrome. Little information is available regarding anesthetic management for CBD patients. Our patient was a 55-year-old man with CBD complicated by central sleep apnea (CSA). Due to the risk of perioperative breathing instability associated with anesthetic use, a laryngeal mask airway was used during anesthesia with propofol. Spontaneous respiration was stable under general anesthesia. However, respiratory depression occurred following surgery, necessitating insertion of a nasopharyngeal airway. Since no respiratory depression had occurred during maintenance of the airway using the laryngeal mask, we suspected an upper airway obstruction caused by displacement of the tongue due to residual propofol. Residual anesthetics may cause postoperative respiratory depression in patients with CBD. Therefore, continuous postoperative monitoring of SpO
and preparations to support postoperative ventilation are necessary.